PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 6/26

Market Analysis and Trades for 6/26

PharmD_KS's avatar
PharmD_KS
Jun 25, 2025
∙ Paid
6

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 6/26
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

We had some additional reasons to be cautious on rips into today, but the plan still called for selectively buying dips. The first location of interest was 6138.25-6139.75 which put in the overnight low (6138.25). The second area of interest was 6130-6132 which put in the cash hours low of day (6130.75). Each of these was worth roughly 20 handles.

Today was a great example of the importance of patience, particularly on a day with timeframe conflict. Buyers are in full control of all time frames but sellers controlled effectively the whole day after the open. The overnight long was the easiest trade today. For those who shorted today it was a brutal (but ultimately effective) grind. The long off low of day required patience but ended up a relatively sweat-free trade.

Was today just some one-off weakness or can we expect some additional reversion lower here?

Paid Content Below or in the Discord

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share